Sintilimab improves survival in advanced non-metastatic nasopharyngeal carcinoma
1. Patients in the sintilimab group reported a significantly greater event-free survival at 36 months compared to the standard therapy ...
1. Patients in the sintilimab group reported a significantly greater event-free survival at 36 months compared to the standard therapy ...
1. In this case-control study, those with tongue cancer were found to have ten-fold increases in rates of inflammatory tongue ...
1. In this target emulation trial, parathyroidectomy did not affect long-term renal function in adults with primary hyperparathyroidism (PHPT). 2. ...
1. Fewer patients in the hyperfractionation group reported grade 3 or worse late radiation-induced complications compared to the standard fractionation ...
Click to read this study in JAMA Surgery.
Click to read this study in JAMA Network Open.
1. In this noninferiority trial, medial retropharyngeal lymph node (MRLN)-sparing radiotherapy was found to be noninferior with respect to local ...
1. Participants with post-viral olfactory dysfunction (PVOD) who underwent olfactory training (OT) did not have a clinically meaningful improvement when ...
Click to read this study in JAMA Otolaryngology - Head & Neck Surgery.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.